Is the Durie and Salmon diagnostic classification system for plasma cell dyscrasias still the best choice? Application of three classification systems to a large population-based registry of paraproteinemia and multiple myeloma.
There are a number of systems for diagnosing multiple myeloma, myeloma variants and monoclonal gammopathy of undetermined significance. We compared three systems, those according to Durie and Salmon, to Kyle and Greipp, and to the British Columbia Cancer Agency, using material from a population-based registry of 847 patients with a paraproteinemia or multiple myeloma. Of these, 157 underwent both bone marrow and X-ray examinations and were subsequently included in our analysis. The differences between the systems were small, even though in only 64% of the cases the diagnosis according to all three systems was identical. The system used by the British Columbia Cancer Agency turned out to be the shortest and easiest system reviewed here. We propose a more frequent application of this system instead of the more commonly used Durie and Salmon and Kyle and Greipp criteria.
Ong
F
F
Comprehensive Cancer Center West, Leiden, The Netherlands.
Hermans
J
J
Noordijk
E M
EM
Kluin-Nelemans
J C
JC
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002965:Classification / Q000379:methods; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000145:classification* / Q000175:diagnosis* / Q000453:epidemiology; D009426:Netherlands; D010265:Paraproteinemias / Q000145:classification* / Q000175:diagnosis* / Q000453:epidemiology; D012042:Registries; D012189:Retrospective Studies